Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
OXUR.BRthis companyOxurion N.V.	€0.00	-0.06×	-0.02×	0.36×	-3.1×	-57867.8%	87.7%	-653.9%	-671.7%	28.9%	378.4%	-844.9%	-0.89×	-3.04×	-403.22×	0.11×	0.0%	3	-47.75	2	C
ARARGX.BRargenx SE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
CYAD.BRCelyad Oncology S.A.	€0.18	8.76×	2.99×	346.32×	-0.79×	-77.4%	9195.2%	-34200.0%	3952.4%	34.1%	366.4%	-94.9%	0×	0.24×	-112.22×	1.92×	0.0%	4	-221.13	4	A-
HYL.BRHyloris Pharmaceuticals S.A.	€4.25	-29.74×	7.11×	26.14×	-20.46×	-236.5%	82.0%	-129.5%	-87.9%	-23.9%	-30.8%	-3.5%	0.06×	1.4×	-12.63×	3.89×	0.0%	2	8.47	1	D+
ONONWD.BROnward Medical N.V.	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Peer median	—	-10.49×	5.05×	186.23×	-10.63×	-157.0%	4638.6%	-17164.8%	1932.2%	5.1%	167.8%	-49.2%	0.03×	0.82×	-62.43×	2.91×	0.0%	3	-106.33	3	—